ANI Transforms With Novitium And Sandoz Deals

Company On Track To File Corticotropin sNDA By End Of Q2

Money_Expansion
After the Novitium deal, ANI acquired Sandoz product assets to expand its portfolio • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Products

More from Generics Bulletin